ATE99946T1 - Lagerstabile orale glucosaminsulfat-dosisformen und verfahren zu deren herstellung. - Google Patents

Lagerstabile orale glucosaminsulfat-dosisformen und verfahren zu deren herstellung.

Info

Publication number
ATE99946T1
ATE99946T1 AT91850031T AT91850031T ATE99946T1 AT E99946 T1 ATE99946 T1 AT E99946T1 AT 91850031 T AT91850031 T AT 91850031T AT 91850031 T AT91850031 T AT 91850031T AT E99946 T1 ATE99946 T1 AT E99946T1
Authority
AT
Austria
Prior art keywords
dosage forms
shelf
manufacture
glucosamine sulphate
stable oral
Prior art date
Application number
AT91850031T
Other languages
English (en)
Inventor
Harry Byron Demopoulos
Original Assignee
Health Maintenance Programs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Maintenance Programs filed Critical Health Maintenance Programs
Application granted granted Critical
Publication of ATE99946T1 publication Critical patent/ATE99946T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT91850031T 1990-02-22 1991-02-12 Lagerstabile orale glucosaminsulfat-dosisformen und verfahren zu deren herstellung. ATE99946T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48357290A 1990-02-22 1990-02-22
EP91850031A EP0444000B1 (de) 1990-02-22 1991-02-12 Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE99946T1 true ATE99946T1 (de) 1994-01-15

Family

ID=23920608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91850031T ATE99946T1 (de) 1990-02-22 1991-02-12 Lagerstabile orale glucosaminsulfat-dosisformen und verfahren zu deren herstellung.

Country Status (5)

Country Link
EP (1) EP0444000B1 (de)
JP (1) JP3135273B2 (de)
AT (1) ATE99946T1 (de)
CA (1) CA2035841C (de)
DE (1) DE69100954T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH690719A5 (it) * 1996-08-19 2000-12-29 Rotta Res B V Amsterdam Swiss Procedimento per la preparazione di sali misti della glucosamina.
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
WO2001001992A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
WO2001001993A1 (en) * 1999-07-02 2001-01-11 Greither, Peter A formulation of glucosamine sulphate
US20030235629A1 (en) 1999-11-06 2003-12-25 Janmarie Hornack Dietary supplement containing alkaline electrolyte buffers
JP2002265365A (ja) * 2001-03-08 2002-09-18 Koyo Chemical Kk 好中球機能抑制剤
WO2003049696A2 (en) * 2001-12-07 2003-06-19 Cargill, Incorporated Glucosamine organic acid adducts
ES2255829B1 (es) 2004-08-06 2007-08-16 Bioiberica, S.A. Nuevo uso de sales de glucosamina.
US7943598B2 (en) 2004-08-06 2011-05-17 Bioiberica, S.A. Use of organic glucosamine salts
ES2534312T3 (es) 2009-05-13 2015-04-21 Wyeth Llc Procedimiento de estabilización de un suplemento dietético que comprende glucosamina
PL3499089T3 (pl) 2017-12-14 2023-05-22 SFS Group International AG Mechanizm śrubowo-toczny z kulkami

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4642237A (en) * 1985-04-24 1987-02-10 Pennwalt Corporation Stable oxidant alpha-amylase concentrates for use in baking
DE3532081A1 (de) * 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物

Also Published As

Publication number Publication date
EP0444000A3 (en) 1991-10-23
CA2035841A1 (en) 1991-08-23
DE69100954T2 (de) 1994-05-05
JP3135273B2 (ja) 2001-02-13
JPH0687762A (ja) 1994-03-29
EP0444000A2 (de) 1991-08-28
EP0444000B1 (de) 1994-01-12
CA2035841C (en) 1996-02-13
DE69100954D1 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
MA19639A1 (fr) Procede de preparation de derives de l'acide cis, endo-2-azabicyclo- (3,3,0) -octane-3- carboxylique et d'agents contenant ces derives
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DK0480077T3 (da) Fremgangsmåde til fremstilling af carnosinsyre
DE69124879D1 (de) Modifizierte Polydextrose und deren Herstellung
HUT56494A (en) Process for producing pharmaceutical compositions suitable for peroral administration of pimobendane
AT380015B (de) Verfahren zur herstellung von 1,5-benzothiazepinderivaten sowie von deren saeureadditionssalzen
ATE99946T1 (de) Lagerstabile orale glucosaminsulfat-dosisformen und verfahren zu deren herstellung.
DE3583209D1 (de) Kontinuierliches verfahren zur herstellung von phosphorsaeure und von calciumsulfat.
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
GB2063264B (en) Treatment of waste stream from adipic acid manufacture
IT1251226B (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
ATE115558T1 (de) Harnstoffderivate, deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen.
DE69020081D1 (de) Verfahren zur Herstellung von 3,3',4,4'-Biphenyltetracarbonsäure von hoher Reinheit oder deren Dianhydrid.
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
DE3774847D1 (de) Trifluorhydroxyaromatische saeure und deren herstellung.
ATE6031T1 (de) Arzneimittel zur oralen verabreichung und verfahren zu seiner herstellung.
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
DE3476520D1 (en) Use of a mixture of compounds for the manufacture of a composition for the treatment of buerger's disease
ATE40687T1 (de) Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE69305250D1 (de) Herstellung von Alkandicarbonsäurederivaten
DE69116216D1 (de) Verwendung von Squalene, Squalane oder deren Mischungen zur Herstellung einer abkühlenden Zusammensetzung zur örtlichen Behandlung von Verbrennungen
ATE264291T1 (de) Zwischenprodukte für die herstellung von guanidinomethylcyclohexancarbonsäure-estern
ATE42087T1 (de) Verfahren zur herstellung von dichtem wasserfreiem natriumcarbonat und nach diesem verfahren hergestelltes dichtes wasserfreies natriumcarbonat.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties